QUALCOMM Incorporated — Form 10-Q Summary
Business context and reporting period. This unaudited quarterly report covers the third quarter and first nine months of fiscal 2023, ended June 25, 2023. Qualcomm earns revenue primarily from QCT semiconductor products and QTL intellectual-property licensing; QSI makes strategic investments. Comparative periods ended June 26, 2022.
Financial performance
| Metric | Q3 FY2023 | Q3 FY2022 | First 9 months FY2023 | First 9 months FY2022 |
|---|---|---|---|---|
| Revenue | $8.451B | $10.936B | $27.189B | $32.805B |
| Operating income | $1.823B | $4.472B | $6.378B | $12.194B |
| Net income | $1.803B | $3.730B | $5.742B | $10.063B |
| Diluted EPS | $1.60 | $3.29 | $5.10 | $8.84 |
| Gross margin | 55% | 56% | 56% | 58% |
| Operating cash flow | Not separately provided for quarter | Not separately provided for quarter | $7.209B | $7.650B |
Quarterly revenue fell 23% year over year and net income fell 52%. Equipment and services revenue declined to $7.108B from $9.266B; licensing revenue declined to $1.343B from $1.670B. Lower QCT gross margin and lower revenue contributed to weaker profitability. Q3 income tax expense was $22M, a 1% effective rate; the nine-month effective rate was 5%. Management estimates a 6% full-year fiscal 2023 effective rate.
- QCT: Q3 revenue was $7.174B, down 24%. Handset revenue was $5.255B, down $1.792B; IoT revenue was $1.485B, down $461M; automotive revenue rose to $434M from $385M. QCT EBT was $1.744B, down from $2.996B.
- QTL: Q3 licensing revenue was $1.230B versus $1.519B; EBT was $811M versus $1.080B.
- Nine-month cash flow and returns: Operating cash flow was $7.209B. Capital expenditures were $1.157B. Cash dividends paid were $2.569B and share repurchases were $2.573B.
Liquidity, debt and balance sheet
At June 25, 2023, cash and cash equivalents were $6.087B and marketable securities were $2.544B, totaling $8.631B, excluding cash classified as held for sale. Current assets were $20.476B and current liabilities were $8.463B. Short-term debt was $914M and long-term debt was $14.530B. The company reported $20.670B of stockholders’ equity. Management believes available liquidity, expected operating cash flow and financing activities are sufficient for working and other capital needs for at least the next 12 months.
Nine-month cash flow benefited from $1.5B net proceeds from the sale of the Veoneer Active Safety business and $1.9B of debt issuance. Cash was used for dividends, repurchases, debt repayments and capital expenditures. Operating cash flow was lower year over year, partly reflecting lower operating liabilities and higher inventory.
Material changes, outlook and notable items
- Management attributed weaker results mainly to macroeconomic pressure on smartphone and device demand and customers reducing elevated inventories. These conditions are expected to continue in the next several quarters and weigh on revenue, results and cash flow.
- QCT handset and IoT sales weakened; handset chipset shipments to certain major OEMs fell. Automotive revenue increased, driven primarily by demand for digital cockpit products. Management expects continued 5G deployment and sees automotive and IoT as diversification opportunities.
- Management expects continued product-cost increases from certain key semiconductor wafer suppliers, intense competition (including customer vertical integration), and near-term elevated inventory. It warned that demand-estimation errors could lead to excess or obsolete inventory and additional reserves.
- Nine-month restructuring charges were $285M, substantially severance-related. Qualcomm expects additional, significant restructuring charges, a substantial portion in Q4 FY2023, with the actions expected to be substantially complete in the first half of FY2024.
- New federal tax rules require capitalization and amortization of research and development costs. Qualcomm expects approximately $1.1B of additional fiscal 2023 cash tax impact; payment deadlines were postponed until October 2023.
- The Veoneer Active Safety business was sold by SSW Partners in June 2023 for $1.5B net proceeds; Qualcomm recognized a $183M after-tax gain in discontinued operations. The Restraint Control Systems business remained held for sale, with sale expected within calendar 2023 subject to conditions.
- No numerical revenue or earnings guidance is provided in the supplied filing text. Management’s outlook is qualitative and subject to macroeconomic, inventory, supply-cost and market uncertainties.
Risks and contingencies
Key risks include customer and licensee concentration, customer development of competing chips, exposure to China and U.S.–China trade restrictions, semiconductor cyclicality and supply-chain dependence, competition, and challenges to the licensing model. Two customers/licensees each represented at least 10% of revenue: together they accounted for 47% of Q3 revenue and 49% of nine-month revenue; identities are not disclosed in the filing excerpt.
Significant legal matters include securities and consumer class actions, ParkerVision patent litigation, and Arm’s dispute over rights related to acquired Nuvia technology; the Arm trial was scheduled for September 2024. Qualcomm states it believes the claims are without merit. The Korea Supreme Court concluded the appeal process concerning the 2015 KFTC matter in April 2023, affirming the lower court judgment. The KFTC closed its 2020 investigation without finding a violation. Qualcomm had not accrued losses for the other described proceedings because it considered losses reasonably possible but not probable and said potential amounts could not be reasonably estimated. An adverse outcome could materially affect results, cash flows or financial condition.
Other unusual comparisons include the prior-year $1.1B benefit from reversal of an EU fine accrual, which increased prior-year income, and higher current-year restructuring expense. The filing states market-risk exposure had not materially changed and that banking-sector developments had not significantly affected the company.
Important facts for investors to verify
- Whether smartphone demand and customer inventory reductions recover as expected, and the resulting impact on QCT revenue, margins and cash flow.
- How concentrated revenue remains among major customers and licensees, and whether customer chip integration or U.S.–China restrictions affect sales.
- The scale and timing of additional restructuring charges and the execution of planned cost reductions.
- The cash-tax consequences of R&D capitalization, including the estimated $1.1B FY2023 impact and October payment deadlines.
- Progress and outcomes in the Arm, licensing, antitrust and other legal matters, including any change in loss estimates or accruals.
- Completion and proceeds of the remaining Veoneer Restraint Control Systems sale, and the treatment of discontinued-operation cash flows.